| Literature DB >> 28193005 |
Jing Li1, Hui Wei2, Stanley R Krystek3, Derek Bond4, Ty M Brender5, Daniel Cohen6, Jena Feiner7, Nels Hamacher3, Johanna Harshman3, Richard Y-C Huang8, Susan H Julien9, Zheng Lin6, Kristina Moore6, Luciano Mueller8, Claire Noriega9, Preeti Sejwal8, Paul Sheppard9, Brenda Stevens9, Guodong Chen8, Adrienne A Tymiak8, Michael L Gross1, Lumelle A Schneeweis6.
Abstract
Epitope mapping the specific residues of an antibody/antigen interaction can be used to support mechanistic interpretation, antibody optimization, and epitope novelty assessment. Thus, there is a strong need for mapping methods, particularly integrative ones. Here, we report the identification of an energetic epitope by determining the interfacial hot-spot that dominates the binding affinity for an anti-interleukin-23 (anti-IL-23) antibody by using the complementary approaches of hydrogen/deuterium exchange mass spectrometry (HDX-MS), fast photochemical oxidation of proteins (FPOP), alanine shave mutagenesis, and binding analytics. Five peptide regions on IL-23 with reduced backbone amide solvent accessibility upon antibody binding were identified by HDX-MS, and five different peptides over the same three regions were identified by FPOP. In addition, FPOP analysis at the residue level reveals potentially key interacting residues. Mutants with 3-5 residues changed to alanine have no measurable differences from wild-type IL-23 except for binding of and signaling blockade by the 7B7 anti-IL-23 antibody. The M5 IL-23 mutant differs from wild-type by five alanine substitutions and represents the dominant energetic epitope of 7B7. M5 shows a dramatic decrease in binding to BMS-986010 (which contains the 7B7 Fab, where Fab is fragment antigen-binding region of an antibody), yet it maintains functional activity, binding to p40 and p19 specific reagents, and maintains biophysical properties similar to wild-type IL-23 (monomeric state, thermal stability, and secondary structural features).Entities:
Mesh:
Substances:
Year: 2017 PMID: 28193005 PMCID: PMC5347259 DOI: 10.1021/acs.analchem.6b03058
Source DB: PubMed Journal: Anal Chem ISSN: 0003-2700 Impact factor: 6.986